Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Non Operating Income: 2016-2020

Historic Non Operating Income for Avadel Pharmaceuticals (AVDL) over the last 4 years, with Jun 2020 value amounting to -$125,000.

  • Avadel Pharmaceuticals' Non Operating Income fell 150.00% to -$125,000 in Q2 2020 from the same period last year, while for Jun 2020 it was -$456,000, marking a year-over-year decrease of 185.23%. This contributed to the annual value of -$435,000 for FY2020, which is 15.08% down from last year.
  • Per Avadel Pharmaceuticals' latest filing, its Non Operating Income stood at -$125,000 for Q2 2020, which was up 59.68% from -$310,000 recorded in Q1 2020.
  • In the past 5 years, Avadel Pharmaceuticals' Non Operating Income ranged from a high of $1.7 million in Q2 2017 and a low of -$2.8 million during Q2 2016.
  • Its 3-year average for Non Operating Income is $108,600, with a median of -$87,500 in 2019.
  • As far as peak fluctuations go, Avadel Pharmaceuticals' Non Operating Income soared by 160.22% in 2017, and later plummeted by 171.82% in 2018.
  • Avadel Pharmaceuticals' Non Operating Income (Quarterly) stood at -$413,000 in 2016, then crashed by 122.03% to -$917,000 in 2017, then spiked by 150.93% to $467,000 in 2018, then plummeted by 74.73% to $118,000 in 2019, then slumped by 150.00% to -$125,000 in 2020.
  • Its Non Operating Income stands at -$125,000 for Q2 2020, versus -$310,000 for Q1 2020 and $118,000 for Q4 2019.